BioSpace News Archive

Precigen, Inc. (Nasdaq: PGEN) today presented positive data at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from the Phase 1 portion of the Phase 1/1b clinical study evaluating safety and efficacy of PRGN-3005 UltraCAR-T® in advanced stage platinum resistant ovarian cancer patients (Abstract# 5590).

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that management will present a company overview at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:00 am PT (11:00 am ET) at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA.

Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that Greg Siller has been appointed Senior Vice President and Chief Commercial Officer of Nevro, effective June 19, 2023.

Applied Energetics, Inc. announced that it has been awarded a $1.148 million Phase II Small Business Technology Transfer contract by the U.S Army to continue the Company’s research, development and testing of an ultra-broadband infrared source capable of disrupting optical infrared sensors within the engagement time window, at tactically relevant ranges.

Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 315,000 shares of the Company’s common stock to three new employees on June 1, 2023.

VolitionRx Limited, a multi-national epigenetics company, announced the closing of its previously announced underwritten public offering of its common stock generating gross proceeds to Volition from the offering of approximately $16.5 million, before deducting underwriting commissions and other offering expenses payable by Volition.

Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California on June 13th at 10:00 a.m. Pacific Daylight Time (PDT)/1:00 p.m. Eastern Daylight Time (EDT).

Atea Pharmaceuticals, Inc. announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, will present a business update at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 2:00 p.m. ET.

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotechnology company dedicated to fighting infectious diseases, announces the award of a grant from CQDM, a Canadian bioresearch consortium, for the collaborative development of a variant-agnostic COVID-19 protein subunit vaccine candidate.

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux) today announced the appointment of Dr. Zachariah (“Zach”) McIver as Vice President, Clinical Development.